LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. Whilst hot flushes are not listed as a common side effect in official prescribing information, some patients report experiencing flushing or warmth sensations during treatment. These symptoms may relate to hormonal changes from significant weight loss, autonomic effects, or unrelated causes such as menopause or thyroid disorders. Understanding the potential mechanisms and management strategies can help patients and healthcare professionals address these concerns effectively whilst continuing treatment safely.
Quick Answer: Hot flushes are not officially listed as a common side effect of Mounjaro, but some patients report them, possibly due to hormonal changes from weight loss or autonomic effects.
Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities. It is administered as a once-weekly subcutaneous injection and represents a novel class of medication known as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
The mechanism of action of Mounjaro involves mimicking the effects of two naturally occurring incretin hormones. By activating both GIP and GLP-1 receptors, tirzepatide enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release when blood glucose is elevated, slows gastric emptying, and reduces appetite. These combined effects lead to improved glycaemic control in people with type 2 diabetes and significant weight loss in those using it for obesity management.
Mounjaro is typically initiated at a low dose (2.5 mg once weekly) for treatment initiation only and gradually increased over several weeks to minimise gastrointestinal side effects. The 2.5 mg dose is not therapeutic for glycaemic control. Maintenance doses range from 5 mg to 15 mg weekly, depending on individual response and tolerability, with dose titration at approximately 4-weekly intervals. The medication is prescribed under specialist or GP supervision and should be used alongside lifestyle modifications, including a balanced diet and regular physical activity.
As with all medicines, Mounjaro can cause side effects. The most commonly reported adverse effects include nausea, vomiting, diarrhoea, constipation, decreased appetite, abdominal discomfort, and injection-site reactions. When used with insulin or sulfonylureas, there is a risk of hypoglycaemia, and dose reductions of these medications may be needed. Gallbladder-related events can also occur with rapid weight loss; seek medical advice if you experience right upper abdominal pain, fever or jaundice. Some patients have reported experiencing hot flushes or flushing sensations during treatment, prompting questions about whether there is a direct link between Mounjaro and these symptoms.
Hot flushes—sudden feelings of warmth, often most intense over the face, neck, and chest—are not listed as a common side effect in the official prescribing information for Mounjaro (MHRA/EMC Summary of Product Characteristics). However, anecdotal reports from patients suggest that some individuals do experience flushing or hot flush-like symptoms while taking tirzepatide. Understanding the potential mechanisms behind these symptoms requires consideration of both the drug's pharmacology and the physiological changes associated with weight loss.
One plausible explanation relates to metabolic and hormonal shifts that occur during significant weight loss. Mounjaro often leads to substantial reductions in body weight, which can alter the balance of sex hormones, particularly oestrogen. Adipose (fat) tissue is a source of oestrogen production, especially in postmenopausal women and men. Rapid weight loss may reduce circulating oestrogen levels, potentially triggering hot flushes similar to those experienced during menopause. This mechanism is not unique to Mounjaro and has been observed with other weight-loss interventions.
Another consideration is the effect of GLP-1 receptor agonists on the autonomic nervous system and thermoregulation. Some evidence suggests that GLP-1 signalling may influence cardiovascular and autonomic function, including heart rate and vascular tone. Flushing or warmth sensations could theoretically result from changes in peripheral blood flow or autonomic regulation, though this remains an area requiring further research.
It is also important to recognise that hot flushes can have multiple causes unrelated to Mounjaro, including:
Menopause or perimenopause in women
Male hypogonadism (low testosterone) in men
Thyroid disorders (hyperthyroidism)
Anxiety or stress
Dietary triggers (spicy foods, caffeine, alcohol)
Other medications (e.g., certain antidepressants, hormone therapies, vasodilators, steroids, some SSRIs/SNRIs)
There is currently no official established link between Mounjaro and hot flushes in regulatory guidance from the MHRA or EMA. Patients experiencing these symptoms should discuss them with their healthcare provider to explore potential contributing factors.
LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
Find out if you’re eligible
If you are experiencing hot flushes while taking Mounjaro, several practical strategies may help reduce their frequency and severity. These approaches focus on lifestyle modifications, environmental adjustments, and, where appropriate, medical interventions.
Lifestyle and environmental measures include:
Dress in layers: Wearing lightweight, breathable fabrics (such as cotton or moisture-wicking materials) allows you to adjust clothing as needed when a hot flush occurs.
Keep cool: Maintain a comfortable room temperature, use fans, and keep cold water or a cool flannel nearby.
Identify and avoid triggers: Common triggers include spicy foods, caffeine, alcohol, hot beverages, and stressful situations. Keeping a symptom diary can help identify personal triggers.
Maintain a healthy weight loss pace: If rapid weight loss is contributing to hormonal fluctuations, discuss with your healthcare provider whether adjusting your Mounjaro dose or weight loss goals might be appropriate. Never adjust your Mounjaro dose without consulting your prescriber.
Stay hydrated: Drinking plenty of water throughout the day can help regulate body temperature.
Practise stress-reduction techniques: Mindfulness, deep breathing exercises, yoga, and regular physical activity can help manage stress-related hot flushes.
Dietary considerations may also play a role. Ensuring adequate intake of phytoestrogens (found in soya products, flaxseeds, and legumes) may provide mild oestrogenic effects for some individuals, though evidence is mixed. Individuals with a history of oestrogen-sensitive cancer or on medicines with known interactions (such as levothyroxine) should seek medical advice before using phytoestrogen supplements or soya products. Avoiding large meals and eating smaller, more frequent meals may reduce postprandial flushing.
For women experiencing menopausal symptoms, it is important to distinguish between hot flushes related to natural hormonal changes and those potentially linked to medication or weight loss. If menopausal symptoms are significant, hormone replacement therapy (HRT) or non-hormonal treatments (such as certain antidepressants, gabapentin, or cognitive behavioural therapy) may be considered. NICE guidance (NG23: Menopause: diagnosis and management) provides recommendations for managing menopausal symptoms, and these options should be discussed with a GP or menopause specialist.
If hot flushes persist or significantly affect quality of life, do not discontinue Mounjaro without medical advice. Your healthcare provider can assess whether the symptoms are related to the medication, underlying health conditions, or other factors, and can recommend appropriate management strategies.
If you suspect your hot flushes may be a side effect of Mounjaro, you can report this through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app).
While hot flushes are often benign and manageable with lifestyle adjustments, certain circumstances warrant prompt medical evaluation. It is important to distinguish between mild, self-limiting symptoms and those that may indicate an underlying health concern or adverse drug reaction.
Contact your GP or healthcare provider if:
Hot flushes are severe, persistent, or worsening despite self-care measures
You experience hot flushes accompanied by chest pain, palpitations, shortness of breath, or dizziness—these may indicate cardiovascular issues requiring urgent assessment. If you have diabetes, check your blood glucose as these symptoms may reflect hypoglycaemia, especially if you take Mounjaro with insulin or sulfonylureas
Hot flushes are associated with unexplained weight loss (beyond expected weight loss from Mounjaro), night sweats, fever, or fatigue, which could suggest thyroid dysfunction, infection, or other systemic conditions
You develop new or worsening anxiety, mood changes, or sleep disturbance significantly affecting daily functioning
You are a woman of reproductive age experiencing irregular periods, unexpected menopausal symptoms, or concerns about fertility
You have a personal or family history of hormone-sensitive conditions (such as breast cancer or endometrial cancer) and are concerned about hormonal changes
You experience right upper abdominal pain, fever or jaundice, which could indicate gallbladder problems (a potential risk with rapid weight loss)
Contact NHS 111 for urgent advice if you have concerning symptoms that are not immediately life-threatening but require prompt assessment.
Seek urgent medical attention (call 999 or attend A&E) if hot flushes are accompanied by:
Severe allergic reaction (anaphylaxis): difficulty breathing, swelling of the face, lips, or throat, or widespread rash
Signs of pancreatitis: severe, persistent abdominal pain radiating to the back, nausea, and vomiting (a known rare but serious side effect of GLP-1 receptor agonists)
Severe symptoms of hyperthyroidism: marked agitation, confusion, high fever, rapid heart rate
Your healthcare provider may wish to perform investigations to identify the underlying cause of hot flushes. These may include:
Blood tests: thyroid function tests (TSH, free T4), follicle-stimulating hormone (FSH) and oestradiol levels (to assess menopausal status), glucose and HbA1c (to monitor diabetes control)
Cardiovascular assessment: blood pressure monitoring, ECG if palpitations or chest symptoms are present
Medication review: to identify potential drug interactions or other medications contributing to symptoms
Never stop taking Mounjaro abruptly without consulting your prescriber, as this may affect your diabetes control or weight management goals. Your healthcare team can work with you to determine whether hot flushes are related to Mounjaro, adjust your treatment plan if necessary, or provide additional support to manage symptoms effectively.
Hot flushes are not listed as a common side effect in official Mounjaro prescribing information, but some patients report them. They may be related to hormonal changes from weight loss, autonomic effects, or unrelated causes such as menopause or thyroid disorders.
Practical strategies include wearing layered, breathable clothing, keeping cool with fans, avoiding triggers (spicy foods, caffeine, alcohol), staying hydrated, and practising stress-reduction techniques. Discuss persistent symptoms with your healthcare provider to explore underlying causes and appropriate treatments.
Contact your GP if hot flushes are severe, persistent, or accompanied by chest pain, palpitations, unexplained weight loss, night sweats, or abdominal pain. Seek urgent medical attention if you experience signs of allergic reaction, severe abdominal pain, or symptoms of hyperthyroidism.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.
